LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Barbara Merckx"
  2. AU="Grossman, Arthur R"

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Pneumococcal vaccination coverage and adherence to recommended dosing schedules in adults

Arne Janssens / Bert Vaes / Chloé Abels / Jonas Crèvecoeur / Pavlos Mamouris / Barbara Merckx / Pieter Libin / Gijs Van Pottelbergh / Thomas Neyens

BMC Public Health, Vol 23, Iss 1, Pp 1-

a repeated cross-sectional study of the INTEGO morbidity registry

2023  Volume 15

Abstract: Abstract Background Since 2014, Belgium’s Superior Health Council has recommended pneumococcal vaccination for adults aged 19–85 years at increased risk for pneumococcal diseases with a specific vaccine administration sequence and timing. Currently, ... ...

Abstract Abstract Background Since 2014, Belgium’s Superior Health Council has recommended pneumococcal vaccination for adults aged 19–85 years at increased risk for pneumococcal diseases with a specific vaccine administration sequence and timing. Currently, Belgium has no publicly funded adult pneumococcal vaccination program. This study investigated the seasonal pneumococcal vaccination trends, evolution of vaccination coverage and adherence to the 2014 recommendations. Methods INTEGO is a general practice morbidity registry in Flanders (Belgium) that represents 102 general practice centres and comprised over 300.000 patients in 2021. A repeated cross-sectional study was performed for the period between 2017 and 2021. Using adjusted odds ratios computed via multiple logistic regression, the association between an individual’s characteristics (gender, age, comorbidities, influenza vaccination status and socioeconomic status) and schedule-adherent pneumococcal vaccination status was assessed. Results Pneumococcal vaccination coincided with seasonal flu vaccination. The vaccination coverage in the population at risk decreased from 21% in 2017 to 18.2% in 2018 and then started to increase to 23.6% in 2021. Coverage in 2021 was highest for high-risk adults (33.8%) followed by 50- to 85-year-olds with comorbidities (25.5%) and healthy 65- to 85-year-olds (18.7%). In 2021, 56.3% of the high-risk adults, 74.6% of the 50+ with comorbidities persons, and 74% of the 65+ healthy persons had an adherent vaccination schedule. Persons with a lower socioeconomic status had an adjusted odds ratio of 0.92 (95% Confidence Interval (CI) 0.87–0.97) for primary vaccination, 0.67 (95% CI 0.60–0.75) for adherence to the recommended second vaccination if the 13-valent pneumococcal conjugate vaccine was administered first and 0.86 (95% CI 0.76–0.97) if the 23-valent pneumococcal polysaccharide vaccine was administered first. Conclusion Pneumococcal vaccine coverage is slowly increasing in Flanders, displaying seasonal peaks in sync with ...
Keywords Adult pneumococcal vaccination ; Vaccination recommendations ; Vaccination schedule adherence ; General practice ; Equity ; Generalized linear model ; Public aspects of medicine ; RA1-1270
Subject code 610
Language English
Publishing date 2023-06-01T00:00:00Z
Publisher BMC
Document type Article ; Online
Database BASE - Bielefeld Academic Search Engine (life sciences selection)

More links

Kategorien

To top